US federal vaccine guidelines for children have been revised, reducing universal recommendations and shifting some vaccines ...
Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback